A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial

نویسندگان

چکیده

In this placebo-controlled phase II randomized clinical trial, we evaluated the safety and immunogenicity of a therapeutic prime-boost vaccine strategy using recombinant DNA (GTU-MultiHIV B clade) followed by boost vaccination with lipopeptide (HIV-LIPO-5) in HIV-infected patients on combined antiretroviral therapy. We show here that is well tolerated, consistently previous studies HIV-1-infected individuals healthy volunteers who received each component individually.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial.

BACKGROUND Although influenza vaccination is recommended in persons infected with HIV-1, its efficacy is unknown. OBJECTIVE To assess the immunogenicity, efficacy, and risks associated with influenza vaccination in persons infected with HIV-1. DESIGN Randomized, double-blind, placebo-controlled trial. SETTING Outpatient military clinic. PATIENTS 102 patients with HIV-1 infection. INTE...

متن کامل

A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection.

Despite substantial clinical benefits, complete eradication of HIV has not been possible using antiretroviral therapy (ART) alone. Strategies that can either eliminate persistent viral reservoirs or boost host immunity to prevent rebound of virus from these reservoirs after discontinuation of ART are needed; one possibility is therapeutic vaccination. We report the results of a randomized, plac...

متن کامل

A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1.

An HIV-vaccine consisting of a DNA prime, recombinant fowlpox virus (rFPV) boost was evaluated in a double-blind placebo controlled trial. One milligram of pHIS-HIV-B expressing mutated gag, pol, env, vpu, tat and rev was administered at weeks 0 and 4 boosted by 5 x 10(7) pfu rFPV-HIV-B expressing gag/pol at week 8. The vaccine regimen was safe, but there was no difference between vaccine (n = ...

متن کامل

gradual erasure of subjectivity: a study of samuel beckett’s trilogy in the light of postmodernism

ساموئل بکت بیشتر از هر نویسنده دیگری در نیم? دوم قرن بیستم با گفتارش زمان? ما را به آستان? از هم پاشیدگی کشانده است، آستانه ای که در آن مدرنیته با سرانجام گریزان اما غیرقابل اجتناب خود مواجه می شود. در این تحقیق روی مفهوم فردیت و محو آن در دوران پسامدرن تاکید شده و در طی آن سعی شده است که فردیت مدرن و پسامدرن در رمان های سه گانه بکت بررسی گردد. تحقیق حاضر یک بررسی کتابخانه ای و کیفی بر روی سه ر...

15 صفحه اول

Pharmacology and immuno-virologic efficacy of once-a-day HAART in African HIV-infected children: ANRS 12103 phase II trial.

OBJECTIVE To assess 12-month survival, pharmacokinetics, immunologic and virologic efficacy, tolerance, compliance and drug resistance in HIV-infected children in Bobo-Dioulasso, Burkina Faso, receiving once-daily highly-active antiretroviral therapy as a combination of didanosine (DDI), lamivudine (3TC) and efavirenz (EFV). METHODS In the ANRS 12103 open phase II trial, HIV-infected children...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Virology

سال: 2021

ISSN: ['1098-5514', '1070-6321', '0022-538X']

DOI: https://doi.org/10.1128/jvi.02165-20